LIVE

Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video

Trending Now

DXY on the backfoot & crude sells off after constructive ceasefire advancements - Newsquawk US Market Open

Totalitarianism Begins With A Denial Of Economics

Fed pricing shifts & Dollar strengthens as Powell strikes hawkish tone - Newsquawk Europe Market Open

Manhattan Apartment Rents Climb To Summer Highs As Mortgage Rates Top 7%

"Big Short" Michael Burry Boosts China Exposure, But Adds Hedges: 13F

MAHA's Nicole Shanahan Shares Vision To Make Small Farms Great Again

In Most U.S. Cities, Social Security Payments Last Married Couples Just 19 Days Or Less

Buffett 13F Confirms Sale Of 100 Million Apple Shares, Other Sales; New Positions In Domino's Pizza And Pool Corp

US stocks declined and the dollar posted a 5th consecutive daily gain after firmer-than-expected PPI and a hawkish Powell - Newsquawk Asia-Pac Market Open

Dollar bid as Treasuries and Equities see selling on hawkish Powell - Newsquawk US Market Wrap

Likely FDA approval for postpartum depression drug pushes Sage Therapeutics stock up 40%

Business November 10, 2017

This article is being updated.

Previous article: A political shock throws Lebanon’s economy back into crisis Prev Next article: Louis C.K. on sex misconduct accusations: 'These stories are true' Next

via CNBC November 10th 2017

MixedTimes.com
Business
Likely FDA approval for postpartum depression drug pushes Sage Therapeutics stock up 40%

© 2015-2024 MixedTimes All Rights Reserved.

Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video